Moderna, Inc. — Director's Dealing 2021

Sep 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2021-09-17

Reporting Person: Andres Juan (See remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-17	Common Stock	M	5000	$12.21	Acquired	5000	Direct
2021-09-17	Common Stock	S	5000	$438.24	Disposed	0	Direct
2021-09-20	Common Stock	M	5000	$12.21	Acquired	5000	Direct
2021-09-20	Common Stock	S	5000	$417.62	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-17	Stock Option (Right to Buy)	$12.21	M	5000	Disposed	2027-08-29	Common Stock (5000)	Direct
2021-09-20	Stock Option (Right to Buy)	$12.21	M	5000	Disposed	2027-08-29	Common Stock (5000)	Direct

Footnotes

F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020, and amended on May 12, 2021.

F2: This option is fully vested and exercisable.